Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin
Open accessAbstract
Abstract: Insulin resistance, oxidative stress, and an abnormal production of adipokines and cytokines are implicated in the pathogenesis of nonalcoholic steatohepatitis (NASH). Recently, we reported a significant improvement in plasma liver enzymes among patients with NASH treated with melatonin. In this study, we investigated the effect of melatonin, administered at a dose of 10 mg/day for 28 days to 16 patients with histologically proven NASH on insulin resistance (HOMA‐IR), on the plasma levels of adiponectin, leptin, ghrelin, and resistin. Additionally, plasma levels of aminotransferases and gamma glutamyltranspeptidase as well as plasma concentrations of melatonin were evaluated. Median baseline values of HOMA‐IR, leptin (ng/mL), and resistin (pg/mL) in patients with NASH were significantly higher in comparison with controls: 4.90 versus 1.60, 10.70 versus 4.30, and 152 versus 91, respectively. Median adiponectin level (μg/mL) was decreased in patients compared to controls: 6.40 versus 16.25; no significant difference in ghrelin levels between patients and controls was found. After melatonin treatment, the median value of HOMA‐IR was significantly reduced by 60% as compared to baseline values, whereas adiponectin, leptin, and ghrelin plasma levels rose significantly by 119%, 33%, and 20%, respectively; the difference between pre‐/posttreatment in plasma resistin levels was not significant. These findings make melatonin a suitable candidate for testing in patients with NASH in the large controlled clinical trials.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327 · see citing works
Regulation of antioxidant enzymes: a significant role for melatonin
Rodrı́guez, C., Mayo, J. C., Sainz, R. M., Antolı́n, I., Herrera, F., Martı́n, V., & Reiter, R. J. (2003) · Journal of Pineal Research · doi:10.1046/j.1600-079x.2003.00092.x · Cited by 1,990 · see citing works
Self-citationRisk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907 · see citing works
Melatonin as a natural ally against oxidative stress: a physicochemical examination
Galano, A., Tan, D. X., & Reiter, R. J. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00916.x · Cited by 1,154 · see citing works
Self-citationLavine, J. E. (2011) · JAMA · doi:10.1001/jama.2011.520 · Cited by 1,105 · see citing works
Epidemiology of Non-Alcoholic Fatty Liver Disease
Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G. (2010) · Digestive Diseases · doi:10.1159/000282080 · Cited by 1,026 · see citing works
Obesity and leptin resistance: distinguishing cause from effect
Myers, M. G., Leibel, R. L., Seeley, R. J., & Schwartz, M. W. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.08.002 · Cited by 906 · see citing works
Pathogenesis of non-alcoholic fatty liver disease
Dowman, J. K., Tomlinson, J., & Newsome, P. N. (2009) · QJM · doi:10.1093/qjmed/hcp158 · Cited by 742 · see citing works
Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications
Kelesidis, T., Kelesidis, I., Chou, S. H.-H., & Mantzoros, C. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00008 · Cited by 667 · see citing works
Leptin in Human Physiology and Pathophysiology
Mantzoros, C. S., Magkos, F., Brinkoetter, M., Sienkiewicz, E., Dardeno, T. A., Kim, S.-Y., Hamnvik, O.-P. R., & Koniaris, A. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00315.2011 · Cited by 593 · see citing works
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2010) · Hepatology · doi:10.1002/hep.23623 · Cited by 561 · see citing works
Melatonin stimulates brain glutathione peroxidase activity
Barlow‐Walden, L., Reiter, R. J., Abe, M., Pablos, M. I., Menéndez-Peláez, A., CHEN, L., & Pöeggeler, B. (1995) · Neurochemistry International · doi:10.1016/0197-0186(94)00154-m · Cited by 549 · see citing works
Self-citationLee, J. H., Chan, J. L., Yiannakouris, N., Kontogianni, M. D., Estrada, E., Seip, R. L., Orlova, C., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030519 · Cited by 546 · see citing works
From the metabolic syndrome to NAFLD or vice versa?
Vanni, E., Bugianesi, E., Kotronen, A., Minicis, S. D., Yki‐Järvinen, H., & Svegliati‐Baroni, G. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.016 · Cited by 494 · see citing works
Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin
Reiter, R. J., Paredes, S. D., Manchester, L. C., & Tan, D.-X. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230903044914 · Cited by 477 · see citing works
Self-citationAdipokines in liver diseases #
Marra, F., & Bertolani, C. (2009) · Hepatology · doi:10.1002/hep.23046 · Cited by 470 · see citing works
Stehle, J. H., Saade, A., Rawashdeh, O., Ackermann, K., Jilg, A., Sebesteny, T., & Maronde, E. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00856.x · Cited by 401 · see citing works
Wolden‐Hanson, T., Mitton, D. R., McCants, R. L., Yellon, S. M., Wilkinson, C. W., Matsumoto, A. M., & Rasmussen, D. D. (2000) · Endocrinology · doi:10.1210/endo.141.2.7311 · Cited by 390 · see citing works
Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
Pοlyzos, S. A., Toulis, K. A., Goulis, D. G., Zavos, C., & Kountouras, J. (2010) · Metabolism · doi:10.1016/j.metabol.2010.09.003 · Cited by 310 · see citing works
The role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease
Pοlyzos, S. A., Kountouras, J., Zavos, C., & Tsiaousi, E. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01176.x · Cited by 277 · see citing works
Associations of Adiponectin, Resistin, and Tumor Necrosis Factor-α with Insulin Resistance
Hivert, M.-F., Sullivan, L. M., Fox, C. S., Nathan, D. M., D’Agostino, R. B., Wilson, P. W. F., & Meigs, J. B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0425 · Cited by 262 · see citing works
Adiponectin, a key adipokine in obesity related liver diseases.
Buechler, C., Wanninger, J., & Neumeier, M. (2011) · PubMed Central · doi:10.3748/wjg.v17.i23.2801 · Cited by 261 · see citing works
Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies
Shetty, S., Kusminski, C. M., & Scherer, P. E. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.02.004 · Cited by 209 · see citing works
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease
Angulo, P., Alba, L. M., Petrovic, L. M., Adams, L. A., Lindor, K. D., & Jensen, M. D. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.020 · Cited by 197 · see citing works
Pagano, C., Soardo, G., Pilon, C., Milocco, C., Basan, L., Milan, G., Donnini, D., Faggian, D., Mussap, M., Plebani, M., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1056 · Cited by 190 · see citing works
Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats
Agil, A., Rosado, I., Ruiz, R., Figueroa, A., Zen, N., & Fernández‐Vázquez, G. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00928.x · Cited by 169 · see citing works
Ríos-Lugo, M. J., Cano, P., Jiménez‐Ortega, V., Fernández‐Mateos, P., Scacchi, P. A., Cardinali, D. P., & Esquifino, A. I. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00798.x · Cited by 168 · see citing works
Adiponectin, a key adipokine in obesity related liver diseases
Christa, Buechler, Josef, Wanninger, Markus, M. L., & Neumeier (2011) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 167 · see citing works
Testosterone Administration Suppresses Adiponectin Levels in Men
Page, S. T., Herbst, K. L., Amory, J. K., Coviello, A. D., Anawalt, B. D., Matsumoto, A. M., & Bremner, W. J. (2005) · Journal of Andrology · doi:10.1002/j.1939-4640.2005.tb02876.x · Cited by 162 · see citing works
Role of melatonin in upper gastrointestinal tract.
Konturek, S. J., Konturek, P. C., Brzozowski, T., & Bubenik, G. A. (2007) · PubMed · Cited by 153 · see citing works
Self-citationResistin as an Intrahepatic Cytokine
Bertolani, C., Sancho‐Bru, P., Failli, P., Bataller, R. A., Aleffi, S., DeFranco, R., Mazzinghi, B., Romagnani, P., Milani, S., Ginès, P., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060081 · Cited by 151 · see citing works
Tsochatzis, E. A., Papatheodoridis, G., & Archimandritis, A. J. (2009) · Mediators of Inflammation · doi:10.1155/2009/831670 · Cited by 140 · see citing works
Melatonin enhances leptin expression by rat adipocytes in the presence of insulin
Alonso‐Vale, M. I. C., Andreotti, S., Peres, S. B., Anhê, G. F., Borges‐Silva, C. N., Cipolla‐Neto, J., & Lima, F. B. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00478.2004 · Cited by 135 · see citing works
Removal of Melatonin Receptor Type 1 Induces Insulin Resistance in the Mouse
Contreras‐Alcantara, S., Baba, K., & Tosini, G. (2010) · Obesity · doi:10.1038/oby.2010.24 · Cited by 133 · see citing works
Nogueira, T. C. A., Lellis‐Santos, C., de Jesus, D. S., Taneda, M., Rodrigues, S. C., do Amaral, F. G., Lopes, A. M. S., Cipolla‐Neto, J., Bordin, S. A., & Anhê, G. F. (2011) · Endocrinology · doi:10.1210/en.2010-1088 · Cited by 122 · see citing works
Baranova, A. V., Gowder, S., Schlauch, K. A., Elariny, H. A., Collantes, R. S., Afendy, A., Ong, J. P., Goodman, Z. D., Chandhoke, V., & Younossi, Z. M. (2006) · Obesity Surgery · doi:10.1381/096089206778392149 · Cited by 111 · see citing works
Ghrelin in chronic liver disease
Tacke, F., Brabant, G. E., Kruck, E., Horn, R., Schöffski, P., Hecker, H., Manns, M. P., & Trautwein, C. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00438-5 · Cited by 109 · see citing works
New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin
Motilva, V., García‐Mauriño, S., Talero, E., & Illanes, M. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00915.x · Cited by 106 · see citing works
Central Resistin Induces Hepatic Insulin Resistance via Neuropeptide Y
Singhal, N. S., Lazar, M. A., & Ahima, R. S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2443-07.2007 · Cited by 95 · see citing works
Alonso‐Vale, M. I. C., Peres, S. B., Vernochet, C., Farmer, S. R., & Lima, F. B. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00705.x · Cited by 92 · see citing works
Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status
Stein, L. L., Dong, M. H., & Loomba, R. S. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0072-z · Cited by 85 · see citing works
Ghrelin and oxidative stress in gastrointestinal tract
Suzuki, H., Matsuzaki, J., & Hibi∥, T. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.10-16gfr · Cited by 83 · see citing works
Gonciarz, M., Gonciarz, Z., Bielański, W., Mularczyk, A., Konturek, P. C., Brzozowski, T., & Konturek, S. J. (2012) · PubMed · Cited by 82 · see citing works
Self-citationThe Potential Adverse Role of Leptin Resistance in Nonalcoholic Fatty Liver Disease
Pοlyzos, S. A., Kountouras, J., Zavos, C., & Deretzi, G. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181ec5c66 · Cited by 82 · see citing works
Serum resistin is not associated with obesity or insulin resistance in humans.
Iqbal, N., Seshadri, P., Stern, L., Loh, J., Kundu, S., Jafar, T., & Samaha, F. F. (2005) · PubMed · Cited by 82 · see citing works
Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats
İşeri, S. Ö., Şener, G., Saǧlam, B., et al. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.08.014 · Cited by 72 · see citing works
Low Ghrelin Concentrations in Nonalcoholic Fatty Liver Disease Are Related to Insulin Resistance
Marchesini, G., Pagotto, U., Bugianesi, E., Iasio, R. D., Manini, R., Vanni, E., Pasquali, R., Melchionda, N., & Rizzetto, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031094 · Cited by 64 · see citing works
Preliminary Evidence That Pharmacologic Melatonin Treatment Decreases Rat Ghrelin Levels
Mustonen, A., Nieminen, P., & Hyvärinen, H. (2001) · Endocrine · doi:10.1385/endo:16:1:43 · Cited by 62 · see citing works
Peschke, E., Schucht, H., & Mühlbauer, E. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00804.x · Cited by 61 · see citing works
Ghrelin and Metabolic Disorders
Ukkola, O. H. (2009) · Current Protein and Peptide Science · doi:10.2174/138920309787315220 · Cited by 57 · see citing works
Gonciarz, M., Gonciarz, Z., Bielański, W., Mularczyk, A., Konturek, P. C., Brzozowski, T., & Konturek, S. J. (2010) · PubMed · Cited by 57 · see citing works
Self-citationGH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia
Granado, M., Martı́n, A. I., López-Menduiña, M., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00308.2007 · Cited by 50 · see citing works
Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis
Yalnız, M., Bahçecioğlu, İ. H., Ataseven, H., Üstündağ, B., İlhan, F., Poyrazoğlu, O. K., & Erensoy, A. (2006) · Mediators of Inflammation · doi:10.1155/mi/2006/34295 · Cited by 49 · see citing works
Celiński, K., Konturek, S. J., Konturek, P. C., Brzozowski, T., Cichoż‐Lach, H., Słomka, M., Płonka, M., Bielański, W., & Reiter, R. J. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00855.x · Cited by 41 · see citing works
Self-citationPeschke, E., Hofmann, K., Bähr, I., Streck, S., Albrecht, E., Wedekind, D., & Mühlbauer, E. (2011) · Diabetologia · doi:10.1007/s00125-011-2138-0 · Cited by 40 · see citing works
Celiński, K., Konturek, P. C., Słomka, M., et al. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00677.x · Cited by 39 · see citing works
Self-citationEfficacy of Antioxidant Treatment in Reducing Resistin Serum Levels: A Randomized Study
Bo, S., Ciccone, G., Durazzo, M., et al. (2007) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0020017 · Cited by 34 · see citing works
Diz-Lois, M. T., García‐Buela, J., Suarez, F., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0508 · Cited by 18 · see citing works
Thiazolidinedione Therapy for Nonalcoholic Steatohepatitis: Go, Stop, or Proceed With Caution?
Harrison, S. A. (2009) · Hepatology · doi:10.1002/hep.23473 · Cited by 11 · see citing works
Murad, A., Hassan, H., Husein, H., et al. (2010) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2010.10872225 · Cited by 10 · see citing works
Mortality in nonalcoholic fatty liver disease: Clues from the cremona study
Adams, L. A. (2011) · Hepatology · doi:10.1002/hep.24445 · Cited by 9 · see citing works
Płonka, M., Konturek, P. C., Bielański, W., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.00040.x · Cited by 6 · see citing works
Self-citationPłonka, M., Konturek, P. C., Bielański, W., et al. (2006) · Alimentary Pharmacology & Therapeutics Symposium Series · doi:10.1111/j.1746-6342.2006.00040.x · Cited by 6 · see citing works
Self-citationOsteopontin: A missing link between hedgehog signaling and fibrosis in nonalcoholic steatohepatitis
Machado, M. V., & Cortez‐Pinto, H. (2010) · Hepatology · doi:10.1002/hep.24118 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Melatonin in type 2 diabetes mellitus and obesity
Karamitri, A., & Jockers, R. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0130-1 · Cited by 268 · see citing works
Circulating leptin in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Polyzos, S. A., Aronis, K. N., Kountouras, J., Raptis, D. D., Vasiloglou, M. F., & Mantzoros, C. S. (2016) · Diabetologia · doi:10.1007/s00125-015-3769-3 · Cited by 248 · see citing works
Leptin in nonalcoholic fatty liver disease: A narrative review
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2015) · Metabolism · doi:10.1016/j.metabol.2014.10.012 · Cited by 235 · see citing works
Is Melatonin the Cornucopia of the 21st Century?
Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M. G., Rizzo, V., Currò, M., Ientile, R., & Caccamo, D. (2020) · Antioxidants · doi:10.3390/antiox9111088 · Cited by 189 · see citing works
Szewczyk-Golec, K., Rajewski, P., Gackowski, M., Mila-Kierzenkowska, C., Wesołowski, R., Sutkowy, P., Pawłowska, M., & Woźniak, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8494107 · Cited by 92 · see citing works
Bahrami, M., Cheraghpour, M., Jafarirad, S., Alavinejad, P., Asadi, F., Hekmatdoost, A., Mohammadi, M., & Yari, Z. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102452 · Cited by 60 · see citing works
Mesri Alamdari, N., Namazi Shabestari, A., Najafipour, F., & Mirmazhari, A. (2024) · Biomedicine Advances · doi:10.34172/bma.05 · Cited by 4 · see citing works
“19,31 Leptin amount did not vary after a 40-day melatonin supplementation in the present study.”
- Authors
- Gonciarz, M., Bielański, W., Partyka, R., Brzozowski, T., Konturek, P. C., Eszyk, J., Celiński, K., Reiter, R. J., & Konturek, S. J.
- Affiliations
- Wojewódzki Szpital Specjalistyczny nr 5 im. św. Barbary w Sosnowcu (PL)
- Jagiellonian University (PL)
- Medical University of Lublin (PL)
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Konturek, Stanislaw J.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2012-07-13
- Volume
- 54
- Issue
- 2
- Pages
- 154-161
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W1485919284
- Cited by
- 56
- References
- 64
- Citations by year
- 2026: 2 · 2024: 5 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 8 · 2018: 6 · 2017: 6 · 2016: 3 · 2015: 4 · 2014: 7 · 2013: 3
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- green
- ruj.uj.edu.pl
- Licence
- Locations
- Journal of Pineal Research (publishedVersion)
- PubMed (publishedVersion)
- Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion)
- Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
- Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- nonalcoholic steatohepatitis, melatonin, insulin resistance, adiponectin, leptin, ghrelin, resistin, adipokines, HOMA-IR, transaminases, gamma-glutamyltranspeptidase, oxidative stress
- MeSH terms
- Adult, Fatty Liver, Female, Humans, Insulin, Male, Melatonin, Leptin, Adiponectin, Resistin, Ghrelin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review